CYP2C gene polymorphisms in North African populations

Area of Science:

• Pharmacogenomics
• Human genetics
• Drug metabolism

Background:

• Cytochrome P450 (CYP450) superfamily genes encode hemoproteins crucial for metabolizing endogenous compounds and foreign chemicals.
• The human CYP2C gene cluster on chromosome 10 is vital for metabolizing numerous clinically significant drugs.
• While CYP2C9 and CYP2C19 are extensively studied, CYP2C8 and CYP2C18 have received less attention, though their importance is increasingly recognized.

Purpose of the Study:

• To investigate the genetic variations within key CYP2C genes in Libyan and Tunisian populations.
• To analyze pharmacogenetic markers in CYP2C8, CYP2C9, and CYP2C19 genes.
• To understand the geographic distribution of genetic variations in North African populations.

Main Methods:

• Genotyping of 7 pharmacogenetic markers across 3 CYP2C genes (CYP2C8, CYP2C9, CYP2C19).
• Analysis of single nucleotide polymorphisms (SNPs) in exons and regulatory regions.
• Principal Component Analysis (PCA) incorporating North African populations and global data from the 1000 Genomes Project and Kidd Laboratory.

Main Results:

• Geographic clustering of populations was observed using PCA, becoming more pronounced with multi-SNP haplotype analysis.
• Identified functional consequences for 5 out of 7 studied SNPs.
• Demonstrated varied genetic dissimilarities between North African populations and other world regions.

Conclusions:

• North African populations exhibit an intermediate genetic position between European and Asian populations.
• Observed genetic variations within and between geographic regions have significant implications for drug metabolism.
• Findings underscore the importance of considering genetic diversity for personalized medicine and predicting adverse drug reactions.